ZUSDURI revenue hits $50.4M, up 73% QoQ
UroGen reported $50.4M in Q2 2026 revenue for ZUSDURI, up 73% sequentially, alongside a patent allowance for protection through 2044 and pipeline updates including NDA submission for UGN-103.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day